New radiotherapy technology, TrueBeam LINAC with HyperSight imaging, offers faster, more precise treatment, improving patient outcomes and experience
1 July 2025: Mater Private Network has announced a €5.6 million investment in Ireland’s first TrueBeam LINACs with HyperSight– an advanced radiotherapy system that uses high-quality imaging to deliver faster, more precise cancer treatment. The new system, now available at its Dublin hospital and soon to be available in its Limerick Radiation Oncology Centre, enables clinicians to target tumours with greater accuracy, improving outcomes, reducing side effects and reducing treatment times for patients.
Today’s announcement builds on a series of strategic investments by Mater Private Network, which has invested €20 million over the last five years to enhance cancer services across its network. This latest upgrade reflects its ongoing commitment to innovation, clinical excellence, and faster access to care.
Hugh Healy, Director of Cancer, Mater Private Network,said: “Today marks a major milestone for cancer care in Ireland and builds on our ongoing investment in oncology services. This is the first time this technology is available in the country. The TrueBeam LINAC with HyperSight is capable of producing high quality scans in just six seconds, enhancing the precision of tumour targeting while making treatment times quicker for patients. Within our network, we will be able to offer best-in-class stereotactic-capable machines incorporating Varian HyperSight and Brainlab Exactrac Dynamic in both the east and west of the country, as part of the newest fleet of LINAC machines and planning CTs. We’re proud to be the first healthcare network in Ireland to introduce this treatment technology, reaffirming our commitment to ensuring that patients have access to the most advanced treatments available.”
Radiation oncology at Mater Private Network is led by a team of seven sub-specialty radiation oncologists, dedicated to delivering personalised, patient-centred care. Working closely with the Medical Oncology Department, and the multidisciplinary team at The Mater Hospitals and UCD Cancer Centre and University Hospital Limerick, the team works to optimise individualised treatment pathways and patient outcomes.
Thanks to improved workflows and more efficient technology, patients referred to Mater Private Network for radiotherapy, including for prostate, brain, lung, and other site-specific cancers, can typically be seen within one week and begin treatment within one month of referral, ensuring expedited access to potentially life-saving care.
Professor Daniel Cagney, Clinical Director of Radiation Oncology, Mater Private Network said: “These new capabilities, including the TrueBeam LINAC with HyperSight and Brainlab Exactrac Dynamic, are transforming how we deliver radiotherapy. With clearer imaging and faster scans, we can ensure more precise treatment and personalised care. As the first and only healthcare network currently offering this technology, we’re ensuring more people have access to world-class treatment close to home. Ultimately, it’s about better outcomes and giving patients confidence and peace of mind during a very difficult time.”
The launch was officially marked with a ribbon-cutting ceremony earlier today at Mater Private Network’s hospital in Dublin.
Read the latest News at IPN HERE
Read IPN July HERE
